Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer and Zhejiang Hisun Pharmaceuticals have signed a memorandum of understanding (MOU) to establish a joint venture, which aims to strengthen the ability of both companies to reach more patients with high-quality and low-cost medicines in the branded generics arena, in China.
Subscribe to our email newsletter
Pfizer and Zhejiang Hisun Pharmaceuticals will explore a potential business collaboration focused on manufacturing cooperation to deliver and commercialize medicines through a local and global sales and marketing infrastructure and research and development of off-patent medicines.
Both parties could contribute select existing products and other relevant assets and capabilities to provide a solid platform for this potential joint venture.